vs
Beam Therapeutics Inc.（BEAM）与PDF SOLUTIONS INC（PDFS）财务数据对比。点击上方公司名可切换其他公司
Beam Therapeutics Inc.的季度营收约是PDF SOLUTIONS INC的1.8倍（$114.1M vs $62.4M），Beam Therapeutics Inc.净利率更高（214.1% vs -0.1%，领先214.2%），Beam Therapeutics Inc.同比增速更快（279.5% vs 24.6%），PDF SOLUTIONS INC自由现金流更多（$7.5M vs $-87.0M）
Beam Therapeutics是一家美国生物技术企业，专注于基因治疗与基因组编辑领域的研发，总部位于马萨诸塞州剑桥市。公司依托CRISPR碱基编辑和先导编辑技术，可通过酶促作用修改DNA序列中的单个核苷酸，且不会造成DNA双链断裂，以此开发相关治疗方案。
PDF Solutions Inc是一家总部位于美国加利福尼亚州圣克拉拉的跨国企业，主营软件业务与工程技术服务，目前在纳斯达克交易所挂牌上市，股票代码为PDFS。
BEAM vs PDFS — 直观对比
营收规模更大
BEAM
是对方的1.8倍
$62.4M
营收增速更快
BEAM
高出254.9%
24.6%
净利率更高
BEAM
高出214.2%
-0.1%
自由现金流更多
PDFS
多$94.6M
$-87.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $114.1M | $62.4M |
| 净利润 | $244.3M | $-48.0K |
| 毛利率 | — | 72.9% |
| 营业利润率 | -15.3% | 5.5% |
| 净利率 | 214.1% | -0.1% |
| 营收同比 | 279.5% | 24.6% |
| 净利润同比 | 370.4% | -108.9% |
| 每股收益（稀释后） | $2.53 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BEAMPDFS
| Q4 25 | $114.1M | $62.4M | ||
| Q3 25 | — | $57.1M | ||
| Q2 25 | — | $51.7M | ||
| Q1 25 | — | $47.8M | ||
| Q4 24 | — | $50.1M | ||
| Q3 24 | — | $46.4M | ||
| Q2 24 | — | $41.7M | ||
| Q1 24 | — | $41.3M |
净利润BEAMPDFS
| Q4 25 | $244.3M | $-48.0K | ||
| Q3 25 | — | $1.3M | ||
| Q2 25 | — | $1.1M | ||
| Q1 25 | — | $-3.0M | ||
| Q4 24 | — | $539.0K | ||
| Q3 24 | — | $2.2M | ||
| Q2 24 | — | $1.7M | ||
| Q1 24 | — | $-393.0K |
毛利率BEAMPDFS
| Q4 25 | — | 72.9% | ||
| Q3 25 | — | 72.3% | ||
| Q2 25 | — | 71.2% | ||
| Q1 25 | — | 72.9% | ||
| Q4 24 | — | 68.3% | ||
| Q3 24 | — | 73.1% | ||
| Q2 24 | — | 70.6% | ||
| Q1 24 | — | 67.3% |
营业利润率BEAMPDFS
| Q4 25 | -15.3% | 5.5% | ||
| Q3 25 | — | 8.5% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | -7.4% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | — | 4.6% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | -4.7% |
净利率BEAMPDFS
| Q4 25 | 214.1% | -0.1% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | -6.3% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | — | 4.8% | ||
| Q2 24 | — | 4.1% | ||
| Q1 24 | — | -1.0% |
每股收益（稀释后）BEAMPDFS
| Q4 25 | $2.53 | $0.00 | ||
| Q3 25 | — | $0.03 | ||
| Q2 25 | — | $0.03 | ||
| Q1 25 | — | $-0.08 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | — | $0.06 | ||
| Q2 24 | — | $0.04 | ||
| Q1 24 | — | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2B | $42.2M |
| 总债务越低越好 | — | $67.0M |
| 股东权益账面价值 | $1.2B | $271.0M |
| 总资产 | $1.5B | $418.7M |
| 负债/权益比越低杠杆越低 | — | 0.25× |
8季度趋势，按日历期对齐
现金及短期投资BEAMPDFS
| Q4 25 | $1.2B | $42.2M | ||
| Q3 25 | — | $35.9M | ||
| Q2 25 | — | $40.4M | ||
| Q1 25 | — | $54.1M | ||
| Q4 24 | — | $114.9M | ||
| Q3 24 | — | $120.2M | ||
| Q2 24 | — | $117.9M | ||
| Q1 24 | — | $122.9M |
总债务BEAMPDFS
| Q4 25 | — | $67.0M | ||
| Q3 25 | — | $67.6M | ||
| Q2 25 | — | $68.1M | ||
| Q1 25 | — | $68.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益BEAMPDFS
| Q4 25 | $1.2B | $271.0M | ||
| Q3 25 | — | $264.4M | ||
| Q2 25 | — | $257.5M | ||
| Q1 25 | — | $249.0M | ||
| Q4 24 | — | $246.0M | ||
| Q3 24 | — | $240.5M | ||
| Q2 24 | — | $232.2M | ||
| Q1 24 | — | $225.4M |
总资产BEAMPDFS
| Q4 25 | $1.5B | $418.7M | ||
| Q3 25 | — | $406.4M | ||
| Q2 25 | — | $391.1M | ||
| Q1 25 | — | $390.0M | ||
| Q4 24 | — | $315.3M | ||
| Q3 24 | — | $307.4M | ||
| Q2 24 | — | $298.0M | ||
| Q1 24 | — | $286.8M |
负债/权益比BEAMPDFS
| Q4 25 | — | 0.25× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.28× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-83.3M | $17.3M |
| 自由现金流经营现金流 - 资本支出 | $-87.0M | $7.5M |
| 自由现金流率自由现金流/营收 | -76.3% | 12.1% |
| 资本支出强度资本支出/营收 | 3.3% | 15.7% |
| 现金转化率经营现金流/净利润 | -0.34× | — |
| 过去12个月自由现金流最近4个季度 | — | $-8.6M |
8季度趋势，按日历期对齐
经营现金流BEAMPDFS
| Q4 25 | $-83.3M | $17.3M | ||
| Q3 25 | — | $3.3M | ||
| Q2 25 | — | $-5.2M | ||
| Q1 25 | — | $8.6M | ||
| Q4 24 | — | $1.6M | ||
| Q3 24 | — | $9.3M | ||
| Q2 24 | — | $684.0K | ||
| Q1 24 | — | $-1.9M |
自由现金流BEAMPDFS
| Q4 25 | $-87.0M | $7.5M | ||
| Q3 25 | — | $-2.9M | ||
| Q2 25 | — | $-13.8M | ||
| Q1 25 | — | $535.0K | ||
| Q4 24 | — | $-4.0M | ||
| Q3 24 | — | $5.1M | ||
| Q2 24 | — | $-4.6M | ||
| Q1 24 | — | $-3.9M |
自由现金流率BEAMPDFS
| Q4 25 | -76.3% | 12.1% | ||
| Q3 25 | — | -5.1% | ||
| Q2 25 | — | -26.6% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | -8.0% | ||
| Q3 24 | — | 11.0% | ||
| Q2 24 | — | -11.1% | ||
| Q1 24 | — | -9.4% |
资本支出强度BEAMPDFS
| Q4 25 | 3.3% | 15.7% | ||
| Q3 25 | — | 10.8% | ||
| Q2 25 | — | 16.5% | ||
| Q1 25 | — | 17.0% | ||
| Q4 24 | — | 11.3% | ||
| Q3 24 | — | 9.0% | ||
| Q2 24 | — | 12.8% | ||
| Q1 24 | — | 4.9% |
现金转化率BEAMPDFS
| Q4 25 | -0.34× | — | ||
| Q3 25 | — | 2.54× | ||
| Q2 25 | — | -4.55× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.98× | ||
| Q3 24 | — | 4.20× | ||
| Q2 24 | — | 0.40× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BEAM
| Pfizer | $109.1M | 96% |
| Other | $5.0M | 4% |
PDFS
| Volumebased | $38.0M | 61% |
| Other | $24.4M | 39% |
